Cancer vaccines from cryogenically silicified tumour cells functionalized with pathogen-associated molecular patterns

Area of Science:

• Oncology
• Immunology
• Materials Science

Background:

• Personalized cancer vaccines require enhanced immunogenicity.
• Current methods for autologous tumor cell vaccines have limitations.

Purpose of the Study:

• To develop a novel method for producing effective personalized cancer vaccines.
• To investigate the immunogenicity and efficacy of silicified tumor cell vaccines.

Main Methods:

• Cryogenic silicification of tumor cells to preserve antigens within silica layers.
• Surface decoration with pathogen-associated molecular patterns to mimic pathogens.
• Evaluation of vaccine efficacy in syngeneic mouse models of ovarian cancer.

Main Results:

• Silicified cancer vaccines activated dendritic cells and enhanced T cell-mediated tumor antigen presentation.
• Vaccination promoted CD4+ T cell polarization towards a T-helper-1 phenotype.
• Complete tumor eradication and long-term survival were achieved in mice.
• The vaccine synergized with cisplatin in established disease settings.
• Silicified cells demonstrated stability for dehydration and room-temperature storage.

Conclusions:

• Cryogenic silicification offers a promising strategy for developing potent personalized cancer vaccines.
• This method preserves tumor antigens and enhances anti-tumor immunity.
• The technology is adaptable for various tumor types and facilitates storage and transport.